Pharma · Private company
Dr. Reddy's Laboratories Limited, India
Track this companyFree. Adds Dr. Reddy's Laboratories Limited, India to your Dealase workspace and tells you when its record changes.
Clinical trials251 recruiting or active
Pipeline programs39From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline39
- Abametapir Lotion 0.74% w/wPhase 3 · Head Lice InfestationClinicalTrials.gov · fetched Nov 12, 2026
- Arm B: Rituxan®/Mabthera®Phase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- DFD-03Phase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- DFD-03 (0.1% tazarotene) LotionPhase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- DRL_RI (Proposed rituximab biosimilar)Phase 3 · Follicular LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Experimental: Arm A: DRL_RIPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- High dose DFD07 once dailyPhase 3 · Actinic Keratosis (AK)ClinicalTrials.gov · fetched Nov 12, 2026
- High dose DFD07 twice dailyPhase 3 · Actinic Keratosis (AK)ClinicalTrials.gov · fetched Nov 12, 2026
- Low dose DFD07 once dailyPhase 3 · Actinic Keratosis (AK)ClinicalTrials.gov · fetched Nov 12, 2026
- MabThera®Phase 3 · Follicular LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle LotionPhase 3 · Head Lice InfestationClinicalTrials.gov · fetched Nov 12, 2026
- DFD-03 Lotion, 0.1%Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- DFD-03 Vehicle Lotion 0%Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- DFN-11Phase 2 · Rapidly Escalating MigraineClinicalTrials.gov · fetched Nov 12, 2026
- DFN-15 (Celecoxib Oral Solution) 125 mgPhase 2 · Acute PainClinicalTrials.gov · fetched Nov 12, 2026
- DFN-15 (Celecoxib Oral Solution) 250 mgPhase 2 · Acute PainClinicalTrials.gov · fetched Nov 12, 2026
- DFN-15 (Celecoxib Oral Solution) 62.5 mgPhase 2 · Acute PainClinicalTrials.gov · fetched Nov 12, 2026
- Group A - Low-Dose Ha44 0.37% w/wPhase 2 · PediculosisClinicalTrials.gov · fetched Nov 12, 2026
- Group B - High Dose Ha44 Gel 0.74% w/wPhase 2 · PediculosisClinicalTrials.gov · fetched Nov 12, 2026
- Ha44 Gel 0.74% w/wPhase 2 · Head Lice InfestationClinicalTrials.gov · fetched Nov 12, 2026
- PPC-06 400 mg BIDPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- PPC-06 400 mg QDPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- PPC-06 600 mgPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Tazarotene Cream, 0.1%Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Tazarotene Lotion, 0.1%Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Tazorac Cream, 0.1%Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Tazorac Vehicle Cream 0%Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- XP 23829 800 mg QDPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- XP23829 400 mg BIDPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- XP23829 400 mg QDPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- 0.1% sodium lauryl sulfatePhase 1 · Head LiceClinicalTrials.gov · fetched Nov 12, 2026
- Abametapir Lotion 0.74% w/wPhase 1 · Head LiceClinicalTrials.gov · fetched Nov 12, 2026
- Ha44Phase 1 · PediculosisClinicalTrials.gov · fetched Nov 12, 2026
- MoxifloxacinPhase 1 · PediculosisClinicalTrials.gov · fetched Nov 12, 2026
- Reference Medicinal ProductPhase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Reference productPhase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Sodium Lauryl SulfatePhase 1 · Head LiceClinicalTrials.gov · fetched Nov 12, 2026
- Test ProductPhase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle LotionPhase 1 · Head LiceClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous RoutePHASE1 · UNKNOWN · started Oct 3, 2023ClinicalTrials.gov NCT06126042 · fetched Nov 12, 2026
- Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 WeeksPHASE1 · COMPLETED · started Sep 30, 2022ClinicalTrials.gov NCT05597462 · fetched Nov 12, 2026
- A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)PHASE3 · COMPLETED · started Mar 29, 2022ClinicalTrials.gov NCT05343455 · fetched Nov 12, 2026
- A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.PHASE3 · COMPLETED · started Mar 14, 2022ClinicalTrials.gov NCT05296629 · fetched Nov 12, 2026
- A Phase III Transition Study of DRL Rituximab to Reference Medicinal ProductsPHASE3 · COMPLETED · started Apr 8, 2020ClinicalTrials.gov NCT04268771 · fetched Nov 12, 2026
- Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular LymphomaPHASE3 · COMPLETED · started May 15, 2019ClinicalTrials.gov NCT03976102 · fetched Nov 12, 2026
- Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15PHASE2 · COMPLETED · started Jun 19, 2018ClinicalTrials.gov NCT03554772 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)PHASE2 · COMPLETED · started Jan 25, 2018ClinicalTrials.gov NCT03421197 · fetched Nov 12, 2026
- A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne VulgarisPHASE2 · COMPLETED · started Oct 4, 2017ClinicalTrials.gov NCT03599193 · fetched Nov 12, 2026
- A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne VulgarisPHASE2 · COMPLETED · started Aug 21, 2017ClinicalTrials.gov NCT03341910 · fetched Nov 12, 2026
- A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne VulgarisPHASE3 · COMPLETED · started Jul 31, 2017ClinicalTrials.gov NCT03290027 · fetched Nov 12, 2026
- A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 WeeksPHASE3 · COMPLETED · started Jul 6, 2017ClinicalTrials.gov NCT03292640 · fetched Nov 12, 2026
- A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment PeriodPHASE2_PHASE3 · COMPLETED · started Feb 14, 2017ClinicalTrials.gov NCT03116698 · fetched Nov 12, 2026
- Efficacy, Tolerability, and Safety of DFN-15PHASE3 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT03009019 · fetched Nov 12, 2026
- Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating MigrainePHASE2 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02571049 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type PsoriasisPHASE2 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02173301 · fetched Nov 12, 2026
- Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice InfestationPHASE3 · COMPLETED · started Feb 1, 2014ClinicalTrials.gov NCT02062060 · fetched Nov 12, 2026
- A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice InfestationPHASE3 · COMPLETED · started Feb 1, 2014ClinicalTrials.gov NCT02060903 · fetched Nov 12, 2026
- Dermal Safety Study to Evaluate Potential Irritation of Abametapir LotionPHASE1 · COMPLETED · started Jan 1, 2014ClinicalTrials.gov NCT02061813 · fetched Nov 12, 2026
- Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir LotionPHASE1 · COMPLETED · started Jan 1, 2014ClinicalTrials.gov NCT02062073 · fetched Nov 12, 2026
- A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell LymphomaPHASE3 · COMPLETED · started May 30, 2013ClinicalTrials.gov NCT01871727 · fetched Nov 12, 2026
- A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice InfestationPHASE2 · COMPLETED · started Apr 1, 2013ClinicalTrials.gov NCT02010333 · fetched Nov 12, 2026
- Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy VolunteersPHASE1 · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01518699 · fetched Nov 12, 2026
- An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice InfestationPHASE2 · COMPLETED · started Apr 1, 2011ClinicalTrials.gov NCT01336647 · fetched Nov 12, 2026
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.RECRUITING · started Jan 1, 1989ClinicalTrials.gov NCT00404989 · fetched Nov 12, 2026